Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Lexington Biosciences Inc (LXGTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0786 +11.32%
on 10/15/18
0.1096 -20.16%
on 09/17/18
-0.0104 (-10.62%)
since 09/14/18
3-Month
0.0482 +81.54%
on 08/23/18
0.2015 -56.58%
on 08/01/18
-0.1074 (-55.11%)
since 07/13/18
52-Week
0.0482 +81.54%
on 08/23/18
0.4844 -81.94%
on 12/11/17
-0.2921 (-76.95%)
since 10/13/17

Most Recent Stories

More News
Lexington Announces Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Lexington Biosciences Receives HeartSentry USPTO Patent Approval

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to announce the issuance of U.S. Patent No. 10,028,664, which...

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Lexington Engages with Major Canadian University and Provides Clinical Trial Update

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased to advise it has engaged with a dedicated research team at The...

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Lexington Announces Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Lexington Releases Audited Consolidated Financial Statements

Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, has released its audited Consolidated Financial Statements and Management,...

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
2 Stocks That Should Be on Your Radar Now

CORAL GABLES, FL / ACCESSWIRE / November 9, 2017 / Lexington Biosciences, Inc. (LXGTF) is a medical device company that is focusing on measuring and monitoring the cardiovascular system. The company's...

LXGTF : 0.0875 (-8.85%)
ONCS : 1.51 (-0.66%)
2 Stocks To Have On Your Radar On Thursday

CORAL GABLES, FL / ACCESSWIRE / November 2, 2017 / With earnings season upon us, the market continues to gain as tech companies like Apple, Alibaba, and Blue Apron are set to announce earnings ahead of...

LXGTF : 0.0875 (-8.85%)
Lexington Biosciences Receives HeartSentry Trial Units

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct 23, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased...

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Lexington Biosciences Receives HeartSentry Trial Units

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct 23, 2017) - Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company, is pleased...

LNB.CN : 0.110 (-8.33%)
LXGTF : 0.0875 (-8.85%)
Tech Stocks to Keep on Your Radar

CORAL GABLES, FL / ACCESSWIRE / October 20, 2017 / Technology stocks were outpacing the broader U.S. markets on Friday, with shares of tech companies in the S&P 500 jumping more than 0.6% during afternoon...

DXTR : 0.0499 (+42.57%)
LXGTF : 0.0875 (-8.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade LXGTF with:

Key Turning Points

2nd Resistance Point 0.1029
1st Resistance Point 0.0952
Last Price 0.0875
1st Support Level 0.0792
2nd Support Level 0.0709

See More

52-Week High 0.4844
Fibonacci 61.8% 0.3178
Fibonacci 50% 0.2663
Fibonacci 38.2% 0.2148
Last Price 0.0875
52-Week Low 0.0482

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar